TCG Lifesciences appoints Chris Senanayake as Chief Scientific Officer
, NY, US - Jan 15, 2020 -
TCG Lifesciences appoints Boehringers Chris H Senanayake as Chief Scientific Officer
Kolkata, India,January 15, 2020: TCG Lifesciences, a company promoted by New York based Purnendu Chatterjee Group, has today announced the induction of Chris Senanayake, as Chief Scientific Officer (CSO) responsible for delivering highest quality scientific solutions and innovations to its global client base.
Chris is a globally recognized pharma industry innovator and opinion leader in the field of chemical research and development. In his last assignment, he was the Vice President in Boehringer Ingelheim Pharmacutical and led the Chemical Development wing in their USA office. He directed chemical process research and development on an international level and provided leadership to US Chemical Development, Global NCE development in a timely and economical manner.
Swapan Bhattacharya, Managing Director, TCG Lifesciences commented, Dr. Senanayake demonstrates the ability to define and optimize chemical research and development strategies and tactics. He is able to connect the dots between the purely scientific and commercial perspectives and set up creative and effective. We are delighted to welcome Chris into our leadership team and to leverage his expertise and experience to improve our scientific skills and deliver innovative solutions.
TCG Lifesciences is science based company with strong expertise in medicinal chemistry, scale up and analytical sciences. I am looking forward to working with the highly talented and passionate team to improve their process development offerings by employing innovative process technologies and green chemistry applications, said Chris Senanayake.
About TCG Lifesciences Pvt. Ltd.
TCG Lifesciences Pvt. Limited (formerly "Chembiotek Research International") is a leading global Contract Research and Manufacturing Services (CRAMS) company in the area of drug discovery and development. We started our operations in 2001 in Kolkata, India and currently have our presence in the United States, Europe, and Japan. We have a strong talent pool of 850+ qualified and trained scientists (including 200+ PhDs), drawn from the best domestic and international institutes and industry. Our services span chemistry, in vitro and in vivo pharmacology, analytical development and validation, and specialty chemicals. We offer specific/functional solutions to integrated projects across multiple therapeutic areas with specific focus on Inflammation & Pain, Infectious Diseases, Central Nervous System and Oncology. Our research infrastructure includes world-class chemistry and biology laboratories, animal facility, electrophysiology laboratory, BSL 2 laboratory, and cGMP API facilities at our R&D centers and commercial cGMP API production facilities. For More information, please visit www.tcgls.com
Notes totheEditors:
Mr. Swapan Bhattacharya
MD, TCG Lifesciences Pvt. Ltd.
Mr. Chris Senanayake
CSO, TCG Lifesciences Pvt. Ltd.
Senanayakes research interests focus on the development of sustainable manufacturing processes to APIs utilizing green chemistry principles, new synthetic methods for the construction of bioactive molecules and complex heterocycles, and on catalytic, enzymatic, and mechanistic studies. His illustrious career in the pharma industry spanned over 30 years at Merck, Boehringer Ingelheim and Separacor and he was instrumental in delivering several new drugs into the market, including Crixivan, Lunesta, Jardiance, Formotorol and Desvenlafaxine. He co-authored over 500 publications, patents, book chapters and review articles in many areas of synthetic organic chemistry, drug development and design of improved chemical entities. He received the prestigious Siegfried gold medal award for development of practical processes for APIs and Process Chemistry. He serves on the editorial boards of Organic Synthesis, Organic Process Research & Development Journal, Advanced Synthesis and Catalysis Journal, Asian Journal of Organic Chemistry, Beilstein Journal of Organic Chemistry and others.
For Further Details, please contact:
Contact No: 8336001433